Get the Stockscreener App
2.115
1.63%
-0.035
Proqr Therapeutics N V Stock (PRQR) Forecast
The Proqr Therapeutics N V (PRQR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.8327, representing a -60.63% decrease from the current price of $2.115. The highest analyst price target is $1.4604, and the lowest is $0.2051.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PRQR Price Target
Average 1.4678
(-30.60% Downside)
Is Proqr Therapeutics N V (PRQR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 35.41 | Neutral |
| STOCH(9,6) | 16.20 | Buy |
| STOCHRSI(14) | 88.59 | Sell |
| MACD(12,26) | -0.2107 | Buy |
| ADX(14) | 33.84 | Sell |
| William %R | -69.67 | Neutral |
| CCI(14) | -26.22 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.158
Sell
|
2.1657
Sell
|
| MA20 |
2.3255
Sell
|
2.3156
Sell
|
| MA50 |
2.8538
Sell
|
2.6253
Sell
|
| MA100 |
2.7851
Sell
|
2.6544
Sell
|
| MA200 |
2.34
Sell
|
2.4612
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PRQR could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on PRQR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 35.41 indicates that PRQR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 16.2 indicates that PRQR is oversold. This indicates that PRQR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 88.59 indicates that PRQR is oversold. This suggests that PRQR price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.84 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -26.22 indicates that PRQR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term PRQR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Proqr Therapeutics N V financial reports and earnings history, Proqr Therapeutics N V (PRQR) stock could reach $6.4893 by 2030, $7.4997 by 2040 and $23.69 by 2050. See the projected annual prices until 2050 of the Proqr Therapeutics N V stock below:
- Proqr Therapeutics N V (PRQR) is expected to reach an average price of $3.2178 in 2035, with a high prediction of $3.6505 and a low estimate of $3.2978. This indicates an $52.14% rise from the last recorded price of $2.115.
- Proqr Therapeutics N V (PRQR) stock is projected to chart a bullish course in 2040, with an average price target of $7.4516, representing an $252.32% surge from its current level. The forecast ranges from a conservative $7.5016 to a sky-high $7.4997.
- Our analysts predict Proqr Therapeutics N V (PRQR) to jump 626.35% by 2045, soaring from $15.45 to an average price of $15.36, potentially reaching $15.68. While $15.45 is the low estimate, the potential upside is significant.
- Proqr Therapeutics N V (PRQR) stock is expected to climb by 2050, reaching an average of $23.36, a $1,004% jump from its current level. However, a wide range of estimates exists, with high and low targets of $23.69 and $23.53, respectively, highlighting the market's uncertainty.
Proqr Therapeutics N V Stock (PRQR) Year by Year Forecast
Proqr Therapeutics N V Stock (PRQR) Price Forecast for 2025
Proqr Therapeutics N V Stock (PRQR) is expected to reach an average price of $1.4016 in 2025, with a high prediction of $2.777 and a low estimate of $0.0263. This indicates an -33.73% fall from the last recorded price of $2.115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $1.0242 | $0.2051 | $1.4604 | -51.57% |
| April, 2025 | $2.5125 | $0.6989 | $1.7182 | +18.80% |
| May, 2025 | $2.2212 | $2.5862 | $2.5968 | +5.02% |
| June, 2025 | $2.0348 | $2.5148 | $2.7055 | -3.79% |
| July, 2025 | $1.0281 | $2.3084 | $1.8988 | -51.39% |
| August, 2025 | $2.3767 | $1.5127 | $1.4767 | +12.37% |
| September, 2025 | $2.0053 | $2.2453 | $2.0014 | -5.18% |
| October, 2025 | $2.1386 | $1.824 | $1.7948 | +1.12% |
| November, 2025 | $2.2473 | $1.9779 | $1.9773 | +6.25% |
| December, 2025 | $3.2205 | $2.2666 | $2.7305 | +52.27% |
Proqr Therapeutics N V Stock (PRQR) Price Forecast for 2026
The predicted value for Proqr Therapeutics N V (PRQR) in 2026 is set at an average of $1.7575. Estimates vary from a peak of $3.4973 to a trough of $0.0178, indicating an -16.90% surge from the present price of $2.115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.6992 | $2.8492 | $2.5145 | +27.62% |
| February, 2026 | $2.3478 | $2.8478 | $2.7085 | +11.01% |
| March, 2026 | $2.2364 | $2.4864 | $2.0618 | +5.74% |
| April, 2026 | $1.5197 | $1.6351 | $1.4304 | -28.15% |
| May, 2026 | $0.7384 | $1.4184 | $1.469 | -65.09% |
| June, 2026 | $0.047 | $0.0977 | $3.107 | -97.78% |
| July, 2026 | $0.2597 | $0.1003 | $0.5244 | -87.72% |
| August, 2026 | $0.7111 | $0.0461 | $0.8611 | -66.38% |
| September, 2026 | $0.4478 | $0.0178 | $1.8418 | -78.83% |
| October, 2026 | $0.4492 | $0.4867 | $0.6192 | -78.76% |
| November, 2026 | $0.9605 | $0.1748 | $1.0052 | -54.58% |
| December, 2026 | $2.7573 | $0.9259 | $3.4973 | +30.37% |
Proqr Therapeutics N V Stock (PRQR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Proqr Therapeutics N V (PRQR) is $2.0279, with a high forecast of $4.0052 and a low forecast of $0.0505. This indicates an -4.12% decrease from the last price of $2.115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.9386 | $1.8586 | $2.8134 | -8.34% |
| February, 2027 | $2.38 | $1.664 | $3.2547 | +12.53% |
| March, 2027 | $2.1667 | $0.9514 | $2.4553 | +2.45% |
| April, 2027 | $1.5981 | $1.2481 | $3.4127 | -24.44% |
| May, 2027 | $0.3595 | $0.0505 | $1.6534 | -83.00% |
| June, 2027 | $4.0321 | $3.7052 | $3.8492 | +90.64% |
| July, 2027 | $3.9273 | $3.9375 | $3.8425 | +85.69% |
| August, 2027 | $3.983 | $3.9018 | $3.9013 | +88.32% |
| September, 2027 | $3.9246 | $4.0144 | $4.0052 | +85.56% |
| October, 2027 | $3.7699 | $3.7997 | $3.8596 | +78.25% |
| November, 2027 | $3.5716 | $3.6416 | $3.6327 | +68.87% |
| December, 2027 | $3.415 | $3.4848 | $3.5201 | +61.47% |
Proqr Therapeutics N V Stock (PRQR) Price Forecast for 2028
In 2028, Proqr Therapeutics N V (PRQR) is projected to reach an average price of $1.8036, with a high projection of $3.3799 and a low estimate of $0.2273. This indicates an -14.72% fall from the last price of $2.115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.4035 | $3.405 | $3.3799 | +60.92% |
| February, 2028 | $3.3282 | $3.35 | $3.3284 | +57.36% |
| March, 2028 | $3.0204 | $3.03 | $3.1618 | +42.81% |
| April, 2028 | $2.5041 | $2.6241 | $2.9551 | +18.40% |
| May, 2028 | $1.0074 | $2.1974 | $2.4488 | -52.37% |
| June, 2028 | $0.806 | $0.4114 | $0.1132 | -61.89% |
| July, 2028 | $0.6147 | $0.7447 | $0.6953 | -70.94% |
| August, 2028 | $0.5279 | $0.5586 | $0.3843 | -75.04% |
| September, 2028 | $1.0566 | $0.2273 | $0.9266 | -50.04% |
| October, 2028 | $1.0752 | $1.0805 | $0.9312 | -49.16% |
| November, 2028 | $1.1685 | $1.2499 | $1.2738 | -44.75% |
| December, 2028 | $1.3371 | $1.3425 | $1.2672 | -36.78% |
Proqr Therapeutics N V Stock (PRQR) Price Forecast for 2029
The 2029 price forecast for Proqr Therapeutics N V Stock (PRQR) is $3.3493 on average, with a high prediction of $6.68 and a low estimate of $0.0186. This represents an +58.36% increase from the previous price of $2.115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.3304 | $1.2311 | $1.3004 | -37.10% |
| February, 2029 | $1.179 | $1.209 | $1.1897 | -44.25% |
| March, 2029 | $1.0177 | $1.0777 | $1.0637 | -51.88% |
| April, 2029 | $1.2963 | $1.1373 | $1.2163 | -38.71% |
| May, 2029 | $1.0396 | $1.2096 | $1.2003 | -50.85% |
| June, 2029 | $0.5682 | $0.7682 | $0.8342 | -73.13% |
| July, 2029 | $0.2168 | $0.2968 | $0.1568 | -89.75% |
| August, 2029 | $0.0999 | $0.0707 | $1.1692 | -95.28% |
| September, 2029 | $0.0712 | $0.0195 | $0.3359 | -96.63% |
| October, 2029 | $0.5379 | $0.0186 | $0.8326 | -74.57% |
| November, 2029 | $0.2493 | $0.0693 | $0.694 | -88.21% |
| December, 2029 | $7.09 | $0.1247 | $6.68 | +235.22% |
Proqr Therapeutics N V Stock (PRQR) Price Forecast for 2030
Proqr Therapeutics N V Stock (PRQR) is expected to reach an average price of $8.4739 in 2030, with a high forecast of $10.86 and a low forecast of $6.0829. This signifies an +300.66% surge from the last price of $2.115.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.8666 | $6.0829 | $6.4893 | +224.66% |
| February, 2030 | $8.6638 | $8.2459 | $8.2945 | +309.64% |
| March, 2030 | $8.9611 | $9.0911 | $8.6925 | +323.69% |
| April, 2030 | $10.11 | $9.0404 | $9.3384 | +377.94% |
| May, 2030 | $11.33 | $10.34 | $10.86 | +435.76% |
| June, 2030 | $9.6522 | $10.36 | $10.76 | +356.37% |
| July, 2030 | $8.2888 | $9.9301 | $9.4215 | +291.90% |
| August, 2030 | $6.956 | $7.566 | $7.5374 | +228.89% |
| September, 2030 | $7.3233 | $7.084 | $7.0033 | +246.25% |
| October, 2030 | $7.4499 | $7.7699 | $7.9112 | +252.24% |
| November, 2030 | $9.9371 | $7.6392 | $8.0771 | +369.84% |
| December, 2030 | $11.04 | $10.25 | $9.9894 | +422.19% |
3.95%
2.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):